111 related articles for article (PubMed ID: 19255821)
1. Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.
Funke C; Soehn AS; Tomiuk J; Riess O; Berg D
J Neural Transm (Vienna); 2009 Apr; 116(4):443-50. PubMed ID: 19255821
[TBL] [Abstract][Full Text] [Related]
2. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese.
Lee CG; Tang K; Cheung YB; Wong LP; Tan C; Shen H; Zhao Y; Pavanni R; Lee EJ; Wong MC; Chong SS; Tan EK
J Med Genet; 2004 May; 41(5):e60. PubMed ID: 15121788
[No Abstract] [Full Text] [Related]
3. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.
Furuno T; Landi MT; Ceroni M; Caporaso N; Bernucci I; Nappi G; Martignoni E; Schaeffeler E; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenetics; 2002 Oct; 12(7):529-34. PubMed ID: 12360103
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.
Funke C; Tomiuk J; Riess O; Berg D; Soehn AS
J Neural Transm (Vienna); 2009 Jul; 116(7):853-9. PubMed ID: 19475336
[TBL] [Abstract][Full Text] [Related]
5. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Drug Metab Pharmacokinet; 2013; 28(2):138-43. PubMed ID: 22971641
[TBL] [Abstract][Full Text] [Related]
6. Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
Jin J; Xue L; Bai X; Zhang X; Tian Q; Xie A
Neurosci Lett; 2020 Sep; 736():135273. PubMed ID: 32712352
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.
Shahabi HN; Westberg L; Melke J; Håkansson A; Belin AC; Sydow O; Olson L; Holmberg B; Nissbrandt H
J Neural Transm (Vienna); 2009 May; 116(5):567-73. PubMed ID: 19381774
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.
Panczyk M; Balcerczak E; Piaskowski S; Jamroziak K; Pasz-Walczak G; Mirowski M
Int J Colorectal Dis; 2009 Aug; 24(8):895-905. PubMed ID: 19415305
[TBL] [Abstract][Full Text] [Related]
9. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.
Benish RL; Rodriguez B; Zimmerman PA; Mehlotra RK
Infect Genet Evol; 2010 Jan; 10(1):60-7. PubMed ID: 19819348
[TBL] [Abstract][Full Text] [Related]
10. MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?
Zschiedrich K; König IR; Brüggemann N; Kock N; Kasten M; Leenders KL; Kostić V; Vieregge P; Ziegler A; Klein C; Lohmann K
J Neurol; 2009 Jan; 256(1):115-20. PubMed ID: 19184162
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability and haplotype profile of MDR1 in Saudi Arabian males.
Al-Mohizea AM; Alkharfy KM; Bagulb KM; Alghamdi AM; Al-Jenoobi FI; Al-Muhsen S; Halwani R; Parvez MK; Al-Dosari MS
Mol Biol Rep; 2012 Dec; 39(12):10293-301. PubMed ID: 23053935
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population.
Krivulcik T; Sedlak J; Bartosova Z
Neoplasma; 2009; 56(2):101-7. PubMed ID: 19239322
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia.
Shinkai T; De Luca V; Utsunomiya K; Sakata S; Inoue Y; Fukunaka Y; Hwang R; Ohmori O; Kennedy JL; Nakamura J
Neuromolecular Med; 2008; 10(4):362-7. PubMed ID: 18543120
[TBL] [Abstract][Full Text] [Related]
14. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
Myhre R; Klungland H; Farrer MJ; Aasly JO
BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
[TBL] [Abstract][Full Text] [Related]
15. Analysis of MDR1 haplotypes in Parkinson's disease in a white population.
Tan EK; Drozdzik M; Bialecka M; Honczarenko K; Klodowska-Duda G; Teo YY; Tang K; Wong LP; Chong SS; Tan C; Yew K; Zhao Y; Lee CG
Neurosci Lett; 2004 Dec; 372(3):240-4. PubMed ID: 15542248
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism of human MDR1 gene in the Siberian and central Asian populations].
Pel's IaR; Marusin AV; Spiridonova MG; Stepanov VA
Mol Biol (Mosk); 2007; 41(6):982-8. PubMed ID: 18318115
[TBL] [Abstract][Full Text] [Related]
17. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR.
Chen B; Fang J; Zhang W; Jin Z; Yu Z; Cai W
J Clin Lab Anal; 2009; 23(2):110-6. PubMed ID: 19288456
[TBL] [Abstract][Full Text] [Related]
18. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.
Andersen V; Agerstjerne L; Jensen D; Østergaard M; Saebø M; Hamfjord J; Kure E; Vogel U
BMC Med Genet; 2009 Feb; 10():18. PubMed ID: 19250544
[TBL] [Abstract][Full Text] [Related]
19. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
[TBL] [Abstract][Full Text] [Related]
20. Effect of MDR1 haplotype on risk of Parkinson disease.
Tan EK; Chan DK; Ng PW; Woo J; Teo YY; Tang K; Wong LP; Chong SS; Tan C; Shen H; Zhao Y; Lee CG
Arch Neurol; 2005 Mar; 62(3):460-4. PubMed ID: 15767512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
